71![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZUBSOLV® safely and effectively. See full prescribing information for ZUBSOLV. • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZUBSOLV® safely and effectively. See full prescribing information for ZUBSOLV. •](https://www.pdfsearch.io/img/6cdfa4da1839c59da587658d9b75818f.jpg) | Add to Reading ListSource URL: www.zubsolv.comLanguage: English - Date: 2015-01-15 13:51:37
|
---|
72![[removed]MEDICATION GUIDE ZUBSOLV® (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) [removed]MEDICATION GUIDE ZUBSOLV® (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)](https://www.pdfsearch.io/img/a885fa6dce3aff69d2d40182c63d9484.jpg) | Add to Reading ListSource URL: www.zubsolv.comLanguage: English - Date: 2014-10-10 14:54:11
|
---|
73![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUBUTEX® sublingual tablet safely and effectively. See full prescribing information for SUBUTEX sublingual tablet. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUBUTEX® sublingual tablet safely and effectively. See full prescribing information for SUBUTEX sublingual tablet.](https://www.pdfsearch.io/img/000909cf23c6899883d667ea71aee593.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-12-16 14:31:45
|
---|
74![• A marked and intense opioid withdrawal syndrome is highly likely to occur with parenteral misuse of SUBOXONE sublingual tablet by individuals physically dependent on full opioid agonists or by sublingual administrat • A marked and intense opioid withdrawal syndrome is highly likely to occur with parenteral misuse of SUBOXONE sublingual tablet by individuals physically dependent on full opioid agonists or by sublingual administrat](https://www.pdfsearch.io/img/a54bc032c2d0fecfe26aa37a30c05898.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-12-16 14:32:33
|
---|
75![AMERICAN JOURNAL OF LIFESTYLE MEDICINE OnlineFirst, published on October 7, 2009 as doi:[removed][removed] vol. x • no. x American Journal of Lifestyle Medicine AMERICAN JOURNAL OF LIFESTYLE MEDICINE OnlineFirst, published on October 7, 2009 as doi:[removed][removed] vol. x • no. x American Journal of Lifestyle Medicine](https://www.pdfsearch.io/img/93c718b61c1ddf39d6318384ce8ee050.jpg) | Add to Reading ListSource URL: www.intranasal.netLanguage: English - Date: 2009-11-20 23:22:43
|
---|
76![D RU G A ND A LC OHOL D ISORD ERS A ND TRE ATME N T Emergency Department Naloxone Distribution: A Rhode Island Department of Health, Recovery Community, and Emergency Department Partnership to Reduce Opioid Overdose Dea D RU G A ND A LC OHOL D ISORD ERS A ND TRE ATME N T Emergency Department Naloxone Distribution: A Rhode Island Department of Health, Recovery Community, and Emergency Department Partnership to Reduce Opioid Overdose Dea](https://www.pdfsearch.io/img/886e0446fa8452f1ad7424d4ff940a68.jpg) | Add to Reading ListSource URL: www.intranasal.netLanguage: English - Date: 2014-11-16 16:18:46
|
---|
77![Clinical research Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial Ali Mohammad Sabzghabaee1, Nastaran Eizadi-Mood1, Ahmad Yaraghi2, Samaneh Zandifar3 Clinical research Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial Ali Mohammad Sabzghabaee1, Nastaran Eizadi-Mood1, Ahmad Yaraghi2, Samaneh Zandifar3](https://www.pdfsearch.io/img/4390751fb0a884101255d231cd514afd.jpg) | Add to Reading ListSource URL: www.intranasal.netLanguage: English - Date: 2014-11-16 16:18:44
|
---|
78![⏐ FIELD ACTION REPORT ⏐ Saved by the Nose: Bystander-Administered Intranasal Naloxone Hydrochloride for Opioid Overdose | Maya Doe-Simkins, MPH, Alexander Y. Walley, MD, MSc, Andy Epstein, RN, MPH, and Peter Moyer, ⏐ FIELD ACTION REPORT ⏐ Saved by the Nose: Bystander-Administered Intranasal Naloxone Hydrochloride for Opioid Overdose | Maya Doe-Simkins, MPH, Alexander Y. Walley, MD, MSc, Andy Epstein, RN, MPH, and Peter Moyer,](https://www.pdfsearch.io/img/0bfc92ca036578d70d260c579100801f.jpg) | Add to Reading ListSource URL: www.intranasal.netLanguage: English - Date: 2009-09-13 23:02:10
|
---|
79![Injectable Naltrexone for the Treatment Injectable Naltrexone for the Treatment](https://www.pdfsearch.io/img/88b1fa7a4078fce602e82e0ab09eec66.jpg) | Add to Reading ListSource URL: buprenorphine.samhsa.govLanguage: English - Date: 2015-01-06 14:48:10
|
---|
80![Injectable Naltrexone for the Treatment Injectable Naltrexone for the Treatment](https://www.pdfsearch.io/img/ee4936f3f533e408cae7faa4c57532ba.jpg) | Add to Reading ListSource URL: buprenorphine.samhsa.govLanguage: English - Date: 2015-01-06 14:48:10
|
---|